The estimated Net Worth of Amir Avniel is at least $3.68 Milione dollars as of 13 March 2023. Mr. Avniel owns over 1,000 units of Beyond Air stock worth over $176,824 and over the last 7 years he sold XAIR stock worth over $2,041,303. In addition, he makes $1,459,990 as President, Chief Operating Officer e Director at Beyond Air.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Avniel XAIR stock SEC Form 4 insiders trading
Amir has made over 24 trades of the Beyond Air stock since 2018, according to the Form 4 filled with the SEC. Most recently he sold 25,000 units of XAIR stock worth $51,500 on 28 December 2023.
The largest trade he's ever made was selling 68,100 units of Beyond Air stock on 30 June 2022 worth over $443,331. On average, Amir trades about 11,528 units every 65 days since 2018. As of 13 March 2023 he still owns at least 457,027 units of Beyond Air stock.
You can see the complete history of Mr. Avniel stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Amir Avniel biography
Amir Avniel serves as President, Chief Operating Officer, Director of the Company. He has served on AIT Ltd.’s Board since 2011 and became AIT Ltd.’s Chief Executive Officer in August 2014. He has served on our Board and served as our Chief Executive Officer from January 13, 2017 to June 14, 2017. He has more than ten years of management experience in the biotechnology industry. From 2013 through 2014, Mr. Avniel served as Strategy and Business Development of A.B. Seeds, a wholly owned subsidiary of Monsanto Company. Mr. Avniel served as the Chief Executive Officer of Rosetta Green Ltd. from 2010 through 2013 and led Rosetta Green in its acquisition by Monsanto. He also served as the president and the Chief Executive Officer of Rosetta Genomics from 2006 to 2009, and Mr. Avniel is a named inventor in over 20 patent applications. He studied computer science at the Academic College of Tel Aviv - Jaffa Israel and earned a Bachelor’s degree in Social Sciences and Humanities - from Open University in Israel. Prior to his academic studies, he served as an officer in the Israel Defense Force, where he was awarded four commendations for excellence.
What is the salary of Amir Avniel?
As the President, Chief Operating Officer e Director of Beyond Air, the total compensation of Amir Avniel at Beyond Air is $1,459,990. There are 1 executives at Beyond Air getting paid more, with Steven Lisi having the highest compensation of $2,969,660.
How old is Amir Avniel?
Amir Avniel is 46, he's been the President, Chief Operating Officer e Director of Beyond Air since 2017. There are 11 older and no younger executives at Beyond Air. The oldest executive at Beyond Air, Inc. is Michael A. Gaul, 65, who is the Sr. VP of Operations.
What's Amir Avniel's mailing address?
Amir's mailing address filed with the SEC is C/O BEYOND AIR, INC., 900 STEWART AVENUE, SUITE 301, GARDEN CITY, NY, 11530.
Insiders trading at Beyond Air
Over the last 5 years, insiders at Beyond Air have traded over $4,582,444 worth of Beyond Air stock and bought 3,519,117 units worth $12,396,434 . The most active insiders traders include Robert Carey, Steven A. Lisi e Amir Avniel. On average, Beyond Air executives and independent directors trade stock every 17 days with the average trade being worth of $15,492. The most recent stock trade was executed by Steven A. Lisi on 15 August 2024, trading 50,000 units of XAIR stock currently worth $18,500.
What does Beyond Air do?
Beyond Air, Inc., a clinical-stage medical device and biopharmaceutical company, develops nitric oxide (NO) generator and delivery systems. The company is developing LungFit system, a NO generator and delivery system, which is in clinical trials for the treatment of persistent pulmonary hypertension of the newborn; acute viral pneumonia, including COVID-19; bronchiolitis and nontuberculous mycobacteria lung infections; and solid tumors. It operates in Israel, Ireland, Australia, and the European Union. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.
What does Beyond Air's logo look like?
Complete history of Mr. Avniel stock trades at Beyond Air
Beyond Air executives and stock owners
Beyond Air executives and other stock owners filed with the SEC include:
-
Steven Lisi,
Chairman of the Board, Chief Executive Officer -
Amir Avniel,
President, Chief Operating Officer, Director -
Adam Newman,
Chief Legal Officer and General Counsel -
Steven Adam Lisi,
CEO & Chairman -
Duncan Fatkin,
Chief Commercial Officer -
Douglas Beck,
Chief Financial Officer -
Amir Avniel,
Co-Founder, Pres, COO & Director -
Douglas J. Beck CPA, CPA,
Consultant -
William Forbes,
Independent Director -
Erick Lucera,
Independent Director -
Robert Carey,
Independent Director -
Yoori Lee,
Independent Director -
Ron Bentsur,
Independent Director -
Bob Yedid,
IR Contact Officer -
Prof. Andrew R. Colin M.D.,
Chief Medical Officer & Member of Scientific Advisory Board -
Kori-Ann Taylor,
Head of Marketing -
Rebecca Van Doren,
Head of Sales -
Maria Yonkoski,
Head of Investor Relations -
Douglas Quinton Larson,
CFO, Principal Financial Officer & Principal Accounting Officer -
Hila Confino Ph.D.,
Research Project Mang. -
Michael A. Gaul,
Sr. VP of Operations -
Ali Ardakani,
Sr. VP of Device & Bus. Devel. -
Dr. Giora Davidai M.D.,
Chief Medical Officer -
Douglas Quinton Larson,
Chief Financial Officer -
Michael A. Gaul,
Chief Operating Officer -
Jeff Lynn Myers,
Chief Medical Officer